» Articles » PMID: 28884412

Mesenchymal Stem Cells (MSCs) Therapy for Recovery of Fertility: a Systematic Review

Overview
Publisher Springer
Specialty Cell Biology
Date 2017 Sep 9
PMID 28884412
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

In recent years, the mesenchymal stem cells (MSCs) have provided the new opportunities to treat different disorders including infertility. Different studies have suggested that the MSCs have ability to differentiate into germ-like cells under specific induction conditions as well as transplantation to gonadal tissues. The aim of this systematic review was to evaluate the results obtained from different studies on MSCs therapy for promoting fertility. This search was done in PubMed and Science Direct databases using key words MSCs, infertility, therapy, germ cell, azoospermia, ovarian failure and mesenchymal stem cell. Among the more than 11,400 papers, 53 studies were considered eligible for more evaluations. The obtained results indicated that the most studies were performed on MSCs derived from bone marrow and umbilical cord as compared with the other types of MSCs. Different evaluations on animal models as well as in vitro studies supported from their role in the recovery of spermatogenesis and folliculogenesis. Although the data obtained from this systematic review are promising, but the further studies need to assess the efficiency and safety of transplantation of these cells in fertility recovery.

Citing Articles

Therapeutic Potential of Different Injection Methods for Bone Marrow Mesenchymal Stem Cell Transplantation in Buslfan-Induced Male Rat Infertility.

Abdelbaset S, Mohamed Sob M, Mutawa G, El-Dein M, Abou-El-Naga A J Stem Cells Regen Med. 2025; 20(2):26-46.

PMID: 39845505 PMC: 11750064. DOI: 10.46582/jsrm.2002005.


Rehabilitation of N, N'-methylenebisacrylamide-induced DNA destruction in the testis of adult rats by adipose-derived mesenchymal stem cells and conditional medium.

Atia M, Badr El-Deen A, Abdel-Tawab H, Alghriany A Heliyon. 2024; 10(23):e40380.

PMID: 39669145 PMC: 11636104. DOI: 10.1016/j.heliyon.2024.e40380.


Human umbilical cord mesenchymal stem cells restore chemotherapy-induced premature ovarian failure by inhibiting ferroptosis in vitro ovarian culture system.

Chen J, He Z, Xu W, Kang Y, Zhu F, Tang H Reprod Biol Endocrinol. 2024; 22(1):137.

PMID: 39511578 PMC: 11542367. DOI: 10.1186/s12958-024-01310-x.


Application of Mesenchymal Stem Cells in Female Infertility Treatment: Protocols and Preliminary Results.

Chatzianagnosti S, Dermitzakis I, Theotokis P, Kousta E, Mastorakos G, Manthou M Life (Basel). 2024; 14(9).

PMID: 39337944 PMC: 11433628. DOI: 10.3390/life14091161.


Developing biomedical engineering technologies for reproductive medicine.

Zhu Y, Kong B, Liu R, Zhao Y Smart Med. 2024; 1(1):e20220006.

PMID: 39188735 PMC: 11235786. DOI: 10.1002/SMMD.20220006.


References
1.
Asgari H, Akbari M, Yazdekhasti H, Rajabi Z, Navid S, Aliakbari F . Comparison of Human Amniotic, Chorionic, and Umbilical Cord Multipotent Mesenchymal Stem Cells Regarding Their Capacity for Differentiation Toward Female Germ Cells. Cell Reprogram. 2017; 19(1):44-53. DOI: 10.1089/cell.2016.0035. View

2.
Wang Z, Wang Y, Yang T, Li J, Yang X . Study of the reparative effects of menstrual-derived stem cells on premature ovarian failure in mice. Stem Cell Res Ther. 2017; 8(1):11. PMC: 5259841. DOI: 10.1186/s13287-016-0458-1. View

3.
Hyun I . The bioethics of stem cell research and therapy. J Clin Invest. 2010; 120(1):71-5. PMC: 2798696. DOI: 10.1172/JCI40435. View

4.
Anand S, Bhartiya D, Sriraman K, Mallick A . Underlying Mechanisms that Restore Spermatogenesis on Transplanting Healthy Niche Cells in Busulphan Treated Mouse Testis. Stem Cell Rev Rep. 2016; 12(6):682-697. DOI: 10.1007/s12015-016-9685-1. View

5.
Li N, Pan S, Zhu H, Mu H, Liu W, Hua J . BMP4 promotes SSEA-1(+) hUC-MSC differentiation into male germ-like cells in vitro. Cell Prolif. 2014; 47(4):299-309. PMC: 6495181. DOI: 10.1111/cpr.12115. View